酒石酸布托啡诺

酒石酸布托啡诺（CAS 58786-99-5）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

The most common indication for butorphanol is management of migraine using the intranasal spray formulation. It may also be used parenterally for management of moderate-to-severe pain, as a supplement for balanced general anesthesia, and management of pain during labor. Butorphanol is more effective in reducing pain in women than in men. In veterinary use, butorphanol ("Torbugesic") is widely used as a sedative and analgesic in dogs, cats and horses. [Wikipedia]Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

同义词与商品名

Butorphanol tartrate; Stadol; Torbutrol; Stadol NS; Torbugesic; 58786-99-5; Butorphic Injection; levo-BC-2627 tartrate; Dolorex; Moradol; Stadol Preservative Free; 2L7I72RUHN; Butorphanol Tartrate Preservative Free; CHEBI:3243; DTXSID50904569; (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol D-(-)-tartrate (1:1) (salt)

GHS 危害分类

Reported hazard statements	H302 (100%), H361 (98.9%), H370 (55.9%), H372 (57%), H412 (55.9%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H361 (98.9%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

公开数据库对它的描述

butorphanol tartrate · CAS 58786-99-5 · C25H35NO8. UNII 2L7I72RUHN.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。